SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024523
Filing Date
2021-05-06
Accepted
2021-05-06 07:26:58
Documents
67
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-10q_20210331.htm 10-Q 2288346
2 EX-10.1 dyn-ex101_63.htm EX-10.1 841796
3 EX-31.1 dyn-ex311_7.htm EX-31.1 8501
4 EX-31.2 dyn-ex312_6.htm EX-31.2 8622
5 EX-32.1 dyn-ex321_8.htm EX-32.1 4696
6 EX-32.2 dyn-ex322_9.htm EX-32.2 4614
  Complete submission text file 0001564590-21-024523.txt   7681625

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dyn-20210331.xml EX-101.INS 1406373
8 XBRL TAXONOMY EXTENSION SCHEMA dyn-20210331.xsd EX-101.SCH 45857
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dyn-20210331_cal.xml EX-101.CAL 44015
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyn-20210331_def.xml EX-101.DEF 110360
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20210331_lab.xml EX-101.LAB 362973
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20210331_pre.xml EX-101.PRE 275609
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 21895799
SIC: 2834 Pharmaceutical Preparations